Anipamil

Anipamil

SCHEMBL741478

CCCCCCCCCCCCC(C#N)(CCCN(C)CCc1cccc(OC)c1)c1cccc(OC)c1.COc1ccc(CCN(C)CCCC2(c3ccc(OC)c(OC)c3)S(=O)(=O)CCCS2(=O)=O)cc1OC

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.62
SCN2A Q99250 3/20 0.62
SCN3A Q9NY46 3/20 0.62
SIGMAR1 Q99720 2/20 0.46
EBP Q15125 1/20 0.46
ABCB1 P08183 9/20 0.41
CYP3A4 P08684 6/20 0.41
ABCC1 P33527 4/20 0.41
HTR2A P28223 4/20 0.41
HTR2C P28335 4/20 0.41
HTR2B P41595 4/20 0.41
KCNH2 Q12809 3/20 0.41
TSHR P16473 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP2C19 P33261 2/20 0.41
ABCB11 O95342 2/20 0.41
CACNA1F O60840 2/20 0.41
HTR1A P08908 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anipamil SCHEMBL247837 0.81 SIGMAR1 (0.69) SCN1ASCN2ASCN3ASIGMAR1EBP
Anipamil SCHEMBL31479919 0.81 SIGMAR1 (0.69) SCN1ASCN2ASCN3ASIGMAR1EBP
Anipamil SCHEMBL9177433 0.80 SIGMAR1 (0.67) SCN1ASCN2ASCN3ASIGMAR1EBP
Anipamil SCHEMBL7199272 0.80 SIGMAR1 (0.67) SCN1ASCN2ASCN3ASIGMAR1EBP
Tiapamil SCHEMBL93936 0.79 SCN1A (1.00) SCN1ASCN2ASCN3AABCB1CYP3A4
Tiapamil SCHEMBL635113 0.78 SCN1A (0.98) SCN1ASCN2ASCN3AABCB1CYP3A4
SCHEMBL11614948 0.78 SCN1A (0.86) SCN1ASCN2ASCN3AABCB1CYP3A4
SCHEMBL25861795 0.76 SCN1A (0.89) SCN1ASCN2ASCN3AABCB1CYP3A4
Hydrochloric Acid SCHEMBL11607284 0.75 SCN1A (0.87) SCN1ASCN2ASCN3AABCB1CYP3A4
Dagapamil SCHEMBL2110079 0.75 SIGMAR1 (0.60) SCN1ASCN2ASCN3ASIGMAR1EBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430018-A2 BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYMTHASE INHIBITORS Novartis AG (CH) 2012-03-21 EP disclosed
WO-2010130773-A2 BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYMTHASE INHIBITORS NOVARTIS AG (CH) 2010-11-18 WO disclosed